We are live on ! Find out more
Voloridge Investment Management

Voloridge Investment Management Portfolio holdings

AUM $25B
1-Year Est. Return 28.08%
This Fund
S&P 500
This Quarter Est. Return
+3.55%
1 Year Est. Return
+28.08%
3 Year Est. Return
+85.2%
5 Year Est. Return
+73.43%
10 Year Est. Return
+582.16%
AUM
$3.62B
AUM Growth
+$298M
Cap. Flow
+$236M
Cap. Flow %
6.54%
Top 10 Hldgs %
29.26%
Holding
1,260
New
349
Increased
225
Reduced
148
Closed
538

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$311M
2
BA icon
Boeing
BA
+$108M
3
AMZN icon
Amazon
AMZN
+$70.3M
4
XLV icon
State Street Health Care Select Sector SPDR ETF
XLV
+$64.1M
5
CSCO icon
Cisco
CSCO
+$62.6M

Top Sells

Rank Stock Value
1
NFLX icon
Netflix
NFLX
+$144M
2
TSLA icon
Tesla
TSLA
+$64.5M
3
UNH icon
UnitedHealth
UNH
+$51.5M
4
JPM icon
JPMorgan Chase
JPM
+$51.1M
5
DIS icon
Walt Disney
DIS
+$51.1M

Sector Composition

Rank Sector Weight
1 Technology 13.6%
2 Healthcare 11.12%
3 Consumer Discretionary 10.69%
4 Industrials 10.28%
5 Financials 10.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UFS
1251
DELISTED
DOMTAR CORPORATION (New)
UFS
– –
-31,568
Closed -$1.57M
ORBC
1252
DELISTED
ORBCOMM, Inc.
ORBC
– –
-27,838
Closed -$189K
UN
1253
DELISTED
Unilever NV New York Registry Shares
UN
– –
-18,897
Closed -$1.1M
ATTU
1254
DELISTED
Attunity Ltd
ATTU
– –
-22,143
Closed -$519K
MNR
1255
DELISTED
Monmouth Real Estate Investment Corp
MNR
– –
-29,394
Closed -$387K
CZR
1256
DELISTED
Caesars Entertainment Corporation
CZR
– –
-1,046,253
Closed -$9.09M
BHVN
1257
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
– –
-12,964
Closed -$667K
GCI
1258
DELISTED
Gannett Co., Inc
GCI
– –
-27,946
Closed -$295K
FDC
1259
DELISTED
First Data Corporation
FDC
– –
-366,869
Closed -$9.64M
AAN.A
1260
DELISTED
The Aaron's Company Inc Class A
AAN.A
– –
-4,709
Closed -$248K
47 48 49 50
51

Similar funds

Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return
AF
Allworth Financial Folsom, California $24.7B AUM 15.55% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return
Los Angeles Capital Management
Los Angeles Capital Management Los Angeles, California $25.4B AUM 38.46% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
KK
KLP Kapitalforvaltning Oslo, Norway $25.5B AUM 28.18% 1-Year Est. Return
VAI
Vanguard Advisers Inc Malvern, Pennsylvania $25.5B AUM

Voloridge Investment Management's Q2 2019 Portfolio in Review

As of Q2 2019, Voloridge Investment Management held 1,260 positions worth $3.62B, up 9% from $3.32B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Voloridge Investment Management deployed $236M of net new capital in Q2 2019, opening 349 new positions and adding to 225 existing holdings. Its largest new stake was Boeing: 296,231 shares worth $108M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was UnitedHealth, an estimated $51.5M trimmed.

  • Voloridge Investment Management's largest Q2 2019 buy was Boeing: 296,231 shares worth $108M.
  • Voloridge Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q2 2019, an estimated $311M increase.
  • Voloridge Investment Management's biggest Q2 2019 reduction was UnitedHealth, cutting an estimated $51.5M.
  • Voloridge Investment Management fully exited Netflix in Q2 2019, selling an estimated $144M.
  • Voloridge Investment Management's ten largest holdings make up 29% of its $3.62B portfolio in Q2 2019.
  • Voloridge Investment Management opened 349 new positions and closed 538 in Q2 2019.
  • Voloridge Investment Management's portfolio value rose 9% quarter-over-quarter to $3.62B.

Based on Voloridge Investment Management's 13F filing for Q2 2019, filed 14 Aug 2019.